New Delhi, Feb. 10 -- Biovet, a Bharat Biotech group company, has received a licence from the Central Drugs Standard Control Organization (CDSCO) for its lumpy skin disease (LSD) vaccine for dairy cattle.

The firm has claimed that it is the first such vaccine in the world for the highly infectious viral disease that affects cattle. Its symptoms include fever, swelling of the skin, and enlarged lymph nodes.

Developed in collaboration with the Indian Council of Agricultural Research (ICAR), the vaccine named Biolumpivaxin is set to be soon launched commercially, the company said in a statement on Monday.

The quality, safety, and efficacy of the vaccine have been extensively tested at ICAR-National Research Centre on Equines (NRCE), Hisar...